Navigation Links
Ganeden Biotech and Pathway International Announce Exclusive Distribution Partnership
Date:2/3/2010

CLEVELAND, Feb. 3 /PRNewswire/ -- Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30®, today announced a partnership with Pathway International Pty Ltd. to exclusively distribute GanedenBC30 in all Australian and New Zealand markets.

The partnership will provide growth opportunities for Ganeden Biotech through increased distribution channels and access to an exclusive international supply chain network of leading manufacturers in Australia and New Zealand.

"Partnering with Pathway International is an important step in achieving our global expansion goals for 2010," said Andrew Lefkowitz, Ganeden Biotech president and CEO. "We are confident that Pathway International's proven track record in successfully distributing innovative health and wellness ingredients will help our probiotic reach consumers in these markets looking to improve their digestive health and boost immunity with probiotic-enhanced food, beverage and supplement products."

Since 2008, GanedenBC30 has been incorporated in more than 40 products widely distributed throughout North America. Due to the unique ability of the shelf-stable probiotic to survive harsh manufacturing processes, it can be incorporated into a variety of products ranging from frozen yogurt to baked goods.

"We look forward to a long-term relationship with Ganeden Biotech through which we can help introduce GanedenBC30 to new markets and manufacturers interested in innovative functional ingredients," said Wayne Coote, managing director of Pathway International.

About Ganeden Biotech

Founded in 1996, Ganeden Biotech Inc. is based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage® and Sustenex™ brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications, medical foods, nutraceuticals and in animal health industries. GanedenBC30 is self-affirmed GRAS (Generally Recognized As Safe) by an independent panel assembled to assess its safety in use as a food ingredient. For more information about licensing opportunities visit ganedenlabs.com and for probiotic supplement information visit digestiveadvantage.com or sustenex.com.

About Pathway International Pty Ltd.

Pathway is the exclusive distributor in Australia and New Zealand for leading suppliers of high quality and innovative ingredients that add value to the health care and nutrition industries.  For more information visit www.pathway.net.au.

SOURCE Ganeden Biotech Inc.

RELATED LINKS
http://www.ganedenlabs.com
http://www.pathway.net.au

'/>"/>

SOURCE Ganeden Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Ganeden Biotech, Racconto Introduce First Probiotic Pasta Line
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Biotech Finishes on a High in August, Burrill Report Says
4. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
5. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
6. Biotech delists shares from TSXV, continues OTCBB trading
7. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
8. MichBio Announces Formation of Biotechnology Legislative Caucus
9. Oncolytics Biotech Inc. announces approval for UK clinical trial
10. Not just humans benefit from animal biotechnology
11. Biotech adds Central American markets to Sucanon distribution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial planning services from offices headquartered in Hamilton County, is embarking on ... LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... ... 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more ... a multi-function, sealed, LED luminaire that meets the needs of everyone in the patient ... , A 2’ x 4’ model features four modes: reading, ambient, standard ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch ... gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology: